Chai Discovery
CA - San FranciscoBiotechnology
Focus: Chai Discovery is an AI-driven antibody discovery company headquartered in San Francisco, leveraging machine learning to accelerate therapeutic development in neurology and ophthalmology.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
12-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Chai Discovery?
AI assessmentChai Discovery is a high-risk, high-upside play suitable for technologists and scientists betting on AI-first antibody discovery; avoid if you need visibility into near-term clinical validation or financial stability.
Why Work Here
- Ground-floor opportunity at a publicly-traded AI antibody platform with differentiated technology in high-value therapeutic areas (neurology, ophthalmology)
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Chai Discovery
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.